Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

This clinical benefit surpasses the published historical benchmark data from multiple pivotal trials and real-world meta analyses of currently available commercial CD19 CAR T-cell therapy.

Ohtuvayre is due to launch in the US in the third quarter of this year, assisted by a $650 million debt facility that Verona agreed a few months ago to build its commercial capabilities.

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

However, the private education sector has transformed into a ruthless commercial enterprise, prioritising financial gains over intellectual nourishment. Often referred to as the Private Education ...

Find out the winners of each category… Join us as we honor the biggest, boldest and most creative real estate deals done… Don't miss the 2025 Commercial Real Estate Developers Power Breakfast ...

Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration ...

After hours: 18 March at 7:16:59 pm GMT-4 Loading Chart for SNY ...